Identification of novel USH2A mutations: implications for the structure of USH2A protein

被引:74
作者
Dreyer, B
Tranebjaerg, L
Rosenberg, T
Weston, MD
Kimberling, WJ
Nilssen, O [1 ]
机构
[1] Univ Tromso Hosp, Dept Med Genet, N-9037 Tromso, Norway
[2] Univ Tromso, Tromso, Norway
[3] Natl Eye Clin Visually Impaired, Hellerup, Denmark
[4] Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA
关键词
hearing impairment; retinitis pigmentosa; Usher syndrome type II; spectrum of mutations; molecular modeling;
D O I
10.1038/sj.ejhg.5200491
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Usher syndrome type II is an autosomal recessive disorder, characterised by stable hearing impairment from childhood and progressive retinitis pigmentosa from the late teens. Mutations In the USH2A gene, located on 1q41, were recently shown to be responsible for Usher syndrome type IIa. We have investigated the molecular pathology of Usher type II by screening the USH2A gene for mutations in 31 unrelated patients from Denmark and Norway Besides the frequent 2299delG mutation, which accounted for 44% of the disease alleles, a heterogeneous spectrum of mutations was identified. Sixteen new, putative disease-causing mutations were detected, of which 12 were private and four were shared by unrelated patients. The disease-causing mutations were scattered throughout the gene and included six nonsense and seven missense mutations, two deletions and one small insertion. In addition, six non-pathogenic polymorphisms were identified. All missense mutations resulted in major amino acid side-chain alterations. Four missense mutations affected the N-terminal part of USH2A, whereas three missense mutations affected the laminin-type epidermal growth factor-like (LE) domain. The structural consequences of the mutations affecting the LE domain are discussed in relation to the three-dimensional structure of a LE-module of the mouse laminin gamma 1 chain.
引用
收藏
页码:500 / 506
页数:7
相关论文
共 24 条
[1]   Disulfide bond structure of human epidermal growth factor receptor [J].
Abe, Y ;
Odaka, M ;
Inagaki, F ;
Lax, I ;
Schlessinger, J ;
Kohda, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) :11150-11157
[2]   Mutation profile of all 49 exons of the human myosin VIIA gene, and haplotype analysis, in Usher 1B families from diverse origins [J].
Adato, A ;
Weil, D ;
Kalinski, H ;
PelOr, Y ;
Ayadi, H ;
Petit, C ;
Korostishevsky, M ;
BonneTamir, B .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) :813-821
[3]  
Antonarakis SE, 1998, HUM MUTAT, V11, P1
[4]   THE CPG DINUCLEOTIDE AND HUMAN GENETIC-DISEASE [J].
COOPER, DN ;
YOUSSOUFIAN, H .
HUMAN GENETICS, 1988, 78 (02) :151-155
[5]   Mutation of a gene encoding a protein with extracellular matrix motifs in usher syndrome type IIa [J].
Eudy, JD ;
Weston, MD ;
Yao, SF ;
Hoover, DM ;
Rehm, HL ;
Ma-Edmonds, M ;
Yan, D ;
Ahmad, I ;
Cheng, JJ ;
Ayuso, C ;
Cremers, C ;
Davenport, S ;
Moller, C ;
Talmadge, CB ;
Beisel, KW ;
Tamayo, M ;
Morton, CC ;
Swaroop, A ;
Kimberling, WJ ;
Sumegi, J .
SCIENCE, 1998, 280 (5370) :1753-1757
[6]  
Fagerheim T, 1999, J MED GENET, V36, P144
[7]  
GRONDAHL J, 1987, CLIN GENET, V31, P255
[8]   A novel locus for Usher syndrome type II, USH2B, maps to chromosome 3 at p23-24.2 [J].
Hmani, M ;
Ghorbel, A ;
Boulila-Elgaied, A ;
Ben Zina, Z ;
Kammoun, W ;
Drira, M ;
Chaabouni, M ;
Petit, C ;
Ayadi, H .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (03) :363-367
[9]  
Janecke AR, 1999, HUM MUTAT, V13, P133, DOI 10.1002/(SICI)1098-1004(1999)13:2<133::AID-HUMU5>3.0.CO
[10]  
2-U